Superior vena cava syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 33: Line 33:


On microscopic pathology, there are no characteristic findings of superior vena syndrome.
On microscopic pathology, there are no characteristic findings of superior vena syndrome.
==References==


==References==
==References==

Revision as of 22:22, 11 January 2016

Superior Vena Cava Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Superior Vena Cava Syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Superior vena cava syndrome pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Superior vena cava syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Superior vena cava syndrome pathophysiology

CDC on Superior vena cava syndrome pathophysiology

Superior vena cava syndrome pathophysiology in the news

Blogs on Superior vena cava syndrome pathophysiology

Directions to Hospitals Treating Superior vena cava syndrome

Risk calculators and risk factors for Superior vena cava syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Superior vena cava (SVC) syndrome arises from the obstruction of venous blood drainage of the superior vena cava, which is normally is involved in the major blood flow return from head, neck, upper extremities, and upper thorax to the heart. Superior vena cava syndrome is a complication from a partial or complete obstruction due to malignant causes (60%) or benign causes (20%). This syndrome may be caused by the invasion of the venous wall associated with intravascular thrombosis, enlarged nodes, enlarged ascending aorta, or more simply, by extrinsic pressure of a tumor mass against the thin-walled superior vena cava (SVC) which leads to the development of SVC syndrome. SVC syndrome is associated with a number of conditions that include malignant tumors, tuberculosis, histoplasmosis, and syphilis.[1]

Pathogenesis

The superior vena cava (SVC) is the major blood vessel for drainage in the upper body (head, neck, upper extremities, and upper thorax). Extrinsic compression of the superior vena cava by a mediastinal tumor is possible because it has a low intravascular pressure. In addition, the superior vena cava is also surrounded by rigid structures, so it is relatively easy to compress. Moreover, the SVC is thin-walled, and the blood flowing therein is under low pressure. Therefore, when the nodes or ascending aorta enlarge, the SVC is compressed, blood flow slows, and complete occlusion may occur.

Knowledge of the anatomy of the SVC and its relationship to the surrounding lymph nodes is essential to understanding the development of the syndrome. The SVC is formed by the junction of the left and right brachiocephalic veins in the mid third of the mediastinum. The SVC extends caudally for 6 to 8 cm, coursing anterior to the right mainstem bronchus and terminating in the superior right atrium, and extends anteriorly to the right mainstem bronchus. The SVC is joined posteriorly by the azygos vein as it loops over the right mainstem bronchus and lies posterior to and to the right of the ascending aorta. The mediastinal parietal pleura is lateral to the SVC, creating a confined space, and the SVC is adjacent to the right paratracheal, azygous, right hilar, and subcarinal lymph node groups.

Associated Conditions

  • Malignancy[2]
    • Lymph node metastasis
    • Non–small cell lung cancer
    • Small cell lung cancer
    • Lymphoma
    • Metastatic lesions (most commonly from breast and testicular cancers)
  • Infections
  • Iatrogenic intravascular devices
  • Thyroid goiter
  • Thrombosis of SVC
  • Pericardial constriction
  • Idiopathic sclerosing mediastinitis
  • Aortic aneurysm

Gross Pathology

On gross pathology, there are no characteristic findings of superior vena syndrome.

Microscopic Pathology

On microscopic pathology, there are no characteristic findings of superior vena syndrome.

References

  1. Menon A, Gupta A (2015). "Superior vena cava syndrome". Indian J. Med. Res. 142 (3): 350. doi:10.4103/0971-5916.166606. PMC 4669875. PMID 26458355.
  2. National Cancer Institute. http://www.cancer.gov/about-cancer/treatment/side-effects/cardiopulmonary-hp-pdq#link/_102_toc Accessed on January,11 2016

Template:WH Template:WS